GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Contineum Therapeutics CTNM · USD

N/A · US listing · 🇺🇸 United States

Compare

10.30

+8.19%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Contineum Therapeutics

Our reporting

Next results

4 Mar 2027

Due on 4 Mar 2027. Analysts expect earnings of -0.48 a share on revenue of $7.5m.

Past results

Reported against what analysts expected

3 Nov 202629 Oct 202630 Jul 20265 May 20265 Mar 202630 Oct 2025
Earnings per share-0.49-0.45-0.40-0.39-0.49-0.45
Forecast-0.45-0.45-0.45-0.55-0.50-0.58
Forecast$5.7m$5.7m——$7.5m$5.0m

Key events

  1. 5 Apr 2024Listed

Contineum Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.